课题基金 / 基金详情

Development of recombinant proteins with an aim to increase their therapeutic activity by the regulation of intracellular sorting

Development of recombinant proteins with an aim to increase their therapeutic activity by the regulation of intracellular sorting
开发重组蛋白,旨在通过调节细胞内分选来提高其治疗活性
批准号:
10557230
负责人:
SUGIYAMA Yuichi
金额:
$8.06万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

SUGIYAMA Yuichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Biologically active proteins usually exhibit the short plasma half-life, repeated and high doses being necessary to obtain their pharmacological activity in vivo. Since their clearance mechanism is the receptor-mediated endocytosis and subsequent lysosomal degradation in target organs, the aim of this study is to regulate their intracellular sorting in order to avoid such degradation pathway. Hepatocyte growth factor (HGF) was fused with endoplasmic reticulum retention signal and nuclear localization signal by gene recombinant techniques. HGF genes obtained in this way were inserted into PUC-SRaipha vector and transfected into COS-7 cells. HGF produced in the medium was dialyzed and purified by heparin-affinity chromatography and reverse phase HPLC. HGF was iodinated by the chloramine-T method, its molecular weight being checked by SDS-PAGE. The biological activity of each HGF derivative was checked by assessing the stimulatory effect on DNA synthesis in primary cultured rat hepatocytes. After incubating with cell lines which highly express HGF receptor, the trichloroacetic acid-soluble radioactivity in the medium gradually increased after a lag-time. However, the increase in TCA-soluble radioactivity during the incubation period with radiolabeled HGF mutant was much lower, indicating that its intracellular degradation is much slower than the wild-type HGF. Thus, the regulation of the intracellular fate of the endocytosed ligand can be, at least partially, regulated by the insertion of a certain type of signal sequences. However, the stability of such a mutant in the medium was not so much increased probably because of the low efficiency in the recycle of the ligand. Therrefore, further improvement has to be considered to change the sorting after avoiding lysosomal degradation. The dissociation kinetics in the endosomal compartment may be the other target to improve the efficiency of ligand recycle.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
Ke-Xin Liu: "Ligand-induced downregulation of receptor-mediated clearance of hepatocyte growth factor in rats" Am.J.Physiol.275. E835-E842 (1998)
Ke-Xin Liu:“大鼠中配体诱导的受体介导的肝细胞生长因子清除率下调”Am.J.Physiol.275。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
S. Mizuno: "Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease."J Clin Invest. 101. 1827-1834 (1998)
S. Mizuno:“肝细胞生长因子可预防慢性肾病小鼠模型中的肾纤维化和功能障碍。”J Clin Invest。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
加藤将夫: "シグナル配列を持った肝細胞増殖因子のレセプター介在性エンドサイトーシスと細胞内動態の解析"DDS研究の進歩. 7. 71-79 (1998)
Masao Kato:“用信号序列分析肝细胞生长因子的受体介导的内吞作用和细胞内动力学”DDS 研究进展 7. 71-79 (1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
21
    Development of probe drugs for the evaluation of the functions of drug transporters in vivo in humans
    • 批准号:
      20249008
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $29.7万
    • 财政年份:
      2008
    • 负责人:
      SUGIYAMA Yuichi
    • 依托单位:
    Development of the quantitative prediction method of pharmacokinetics with considering the function of metabolic enzymes and transporters
    • 批准号:
      17209005
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.78万
    • 财政年份:
      2005
    • 负责人:
      SUGIYAMA Yuichi
    • 依托单位:
    New strategy for the drug development of CNS acting drugs by regulating drug transport across the blood-brain barrier
    • 批准号:
      15390035
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.94万
    • 财政年份:
      2003
    • 负责人:
      SUGIYAMA Yuichi
    • 依托单位:
    Development of the system for prediction of drug-drug interactions in hepatobiliary transport process
    • 批准号:
      13557219
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.45万
    • 财政年份:
      2001
    • 负责人:
      SUGIYAMA Yuichi
    • 依托单位:
    海外基金